Additional file 5: of Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes

Additional file 1: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

June 2018

Table S1. Prevalence of comorbidities in overweight (Nâ=â14) and obese (12) NAFLD patients. In o...

Additional file 9: Figure S7. of Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

Christopher Papandreou (4411252)
Mònica Bullò (4411249)
Francisco Tinahones (211981)
Miguel Martínez-González (3555266)
Dolores Corella (108667)
Georgios Fragkiadakis (4411246)
José López-Miranda (3167316)
Ramon Estruch (108727)
Montserrat Fitó (540590)
Jordi Salas-Salvadó (108681)

September 2017

Volcano plot [−log10 (p-value) vs. log2 (fold-change)] for the comparison between the baseline and f...

Additional file 3: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

June 2018

Figure S2. FGF19 serum concentrations at 4 h versus C4 values at 6 h after the oral fat tolerance te...

Additional file 2: of Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes

Andreea-Manuela Mirea (5816870)
Erik Toonen (5816864)
Inge Munckhof (6660734)
Isabelle Munsterman (6660737)
Eric Tjwa (6660740)
Martin Jaeger (3465044)
Marije Oosting (202291)
Kiki Schraa (527370)
Joost Rutten (6660743)
Marinette Graaf (6660746)
Niels Riksen (6660749)
Jacqueline Graaf (4259950)
Mihai Netea (3465053)
Cees Tack (5816873)
Triantafyllos Chavakis (5816888)
Leo Joosten (26109)

May 2019

Table S1. Natural logarithm transformed data in our four groups of patients and controls. (DOCX 13 k...

Additional file 1: of Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes

Andreea-Manuela Mirea (5816870)
Erik Toonen (5816864)
Inge Munckhof (6660734)
Isabelle Munsterman (6660737)
Eric Tjwa (6660740)
Martin Jaeger (3465044)
Marije Oosting (202291)
Kiki Schraa (527370)
Joost Rutten (6660743)
Marinette Graaf (6660746)
Niels Riksen (6660749)
Jacqueline Graaf (4259950)
Mihai Netea (3465053)
Cees Tack (5816873)
Triantafyllos Chavakis (5816888)
Leo Joosten (26109)

May 2019

Figure S1. PR3 concentrations measured in plasma samples versus serum samples. (PPTX 65 kb

Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes

Mirea, A.M.
Toonenu, Erik J.M.
Munckhof, I.C. van den
Munsterman, I.D.
Tjwa, E.T.
Jaeger, M.
Oosting, M.
Schraa, K.
Rutten, J.H.W.
Graaf, M. van der
Riksen, N.P.
Graaf, J. de
Netea, M.G.
Tack, C.J.
Chavakis, T.
Joosten, L.A.B.

January 2019

Contains fulltext : 203691.pdf (publisher's version ) (Open Access

Additional file 1: of Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study

Fang Liu (13271)
Hui Zhou (13228)
Lei Cao (134409)
Zhirong Guo (3344273)
Chen Dong (967)
Lugang Yu (223712)
Yiying Wang (3344264)
Chunxing Liu (3344267)
Jing Qiu (273902)
Yong Xue (307664)
Xingxiang Liu (4440544)
Yunfang Xu (3344270)

September 2018

Table S1. Stratified analysis of NAFLD and platelet count in different subgroup. (DOCX 27 kb

Additional file 1: Table S1. of The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease

Shujun Zhang (314599)
Tingting Du (9414)
Jianhua Zhang (6347)
Huiming Lu (39961)
Xuan Lin (1716175)
Junhui Xie (3682897)
Yan Yang (33204)
Xuefeng Yu (329731)

January 2017

Odds ratios for NAFLD in different quartiles of TyG index or ALT in ALT <40 and âĽ40 U/L groups. Ta...

Additional file 3: of Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways

Glenn Gerhard (3518345)
Ivana Malenica (559417)
Lorida Llaci (5514833)
Xin Chu (1423066)
Anthony Petrick (5140781)
Christopher Still (3315645)
Johanna DiStefano (5140787)

July 2018

Figure S1. Box plot of mean (± standard deviation) methylation β values for CGI associated with gene...

Additional file 2: of Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults

Jing Luo (146659)
Qian Chen (18883)
Tianran Shen (1568260)
Xu Wang (28596)
Wanjun Fang (5948006)
Xiaocai Wu (5948009)
Zenan Yuan (5948012)
Gengdong Chen (5948015)
Wenhua Ling (163611)
Yuming Chen (108442)

November 2018

Table S2. Association of serum SHBG levels with metabolic risk factors using multiple linear regress...

Additional file 6: of Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease

Stephanie Breher-Esch (6088193)
Nishika Sahini (668877)
Anna Trincone (6088202)
Christin Wallstab (6088205)
JĂźrgen Borlak (6088208)

December 2018

Table S3. Compilation of NAFLD responsive genes in in-vitro/in-vivo comparisons. (PDF 96 kb

Activation of proteinase 3 contributes to Non-alcoholic Fatty Liver Disease (NAFLD) and insulin resistance

Toonen, E.J.M.
Mirea, A.M.
Tack, C.J.J.
Stienstra, R.
Ballak, D.B.
Diepen, J.A. van
Hijmans, A.G.M.
Chavakis, T.
Dokter, W.H.
Pham, C.T.
Netea, M.G.
Dinarello, C.A.
Joosten, L.A.B.

January 2016

Contains fulltext : 169891.pdf (publisher's version ) (Open Access)Activation of i...

Additional file 1: of Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study

Xiao Ren (1671724)
Dian Shi (6322961)
Jiao Ding (6322970)
Zhi Cheng (729515)
Hai Li (254910)
Juan Li (146180)
Hong Pu (5449697)
Ai Yang (6322982)
Cai He (2298781)
Jian Zhang (1682)
Yu Ma (111665)
Ya Zhang (7980)
Tong Zheng (113302)
Ya Bai (835303)
Ning Cheng (483330)

February 2019

Table S1. Relative Risk of some factors in normal and NAFLD groups. Table S2. Variable scoring list ...

Additional file 1: of Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults

Tilman Kühn (437324)
Tobias Nonnenmacher (5514371)
Disorn Sookthai (3495086)
Ruth Schübel (3397790)
Daniel Quintana Pacheco (5514377)
Oyunbileg von Stackelberg (5514374)
Mirja Graf (5514368)
Theron Johnson (3495092)
Christopher Schlett (5514380)
Romy Kirsten (5514383)
Cornelia Ulrich (3404738)
Rudolf Kaaks (23598)
Hans-Ulrich Kauczor (448631)
Johanna Nattenmüller (3687550)

July 2018

Electronic Supplementary Material: Figure S1. Histogram of MRI-derived liver fat content (%) values....

Additional file 1: of Effect of a high-protein diet with Î˛-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial

Fatemeh Haidari (4530547)
Abdollah Hojhabrimanesh (5984030)
Bizhan Helli (5984033)
Seyed Seyedian (5984036)
Kambiz Ahmadi-Angali (5984039)

November 2018

SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...

Additional file 1: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

June 2018

Table S1. Prevalence of comorbidities in overweight (Nâ=â14) and obese (12) NAFLD patients. In o...

Additional file 9: Figure S7. of Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

Christopher Papandreou (4411252)
Mònica Bullò (4411249)
Francisco Tinahones (211981)
Miguel Martínez-González (3555266)
Dolores Corella (108667)
Georgios Fragkiadakis (4411246)
José López-Miranda (3167316)
Ramon Estruch (108727)
Montserrat Fitó (540590)
Jordi Salas-Salvadó (108681)

September 2017

Volcano plot [−log10 (p-value) vs. log2 (fold-change)] for the comparison between the baseline and f...

Additional file 3: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

June 2018

Figure S2. FGF19 serum concentrations at 4 h versus C4 values at 6 h after the oral fat tolerance te...

Additional file 2: of Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes

Andreea-Manuela Mirea (5816870)
Erik Toonen (5816864)
Inge Munckhof (6660734)
Isabelle Munsterman (6660737)
Eric Tjwa (6660740)
Martin Jaeger (3465044)
Marije Oosting (202291)
Kiki Schraa (527370)
Joost Rutten (6660743)
Marinette Graaf (6660746)
Niels Riksen (6660749)
Jacqueline Graaf (4259950)
Mihai Netea (3465053)
Cees Tack (5816873)
Triantafyllos Chavakis (5816888)
Leo Joosten (26109)

May 2019

Table S1. Natural logarithm transformed data in our four groups of patients and controls. (DOCX 13 k...

Additional file 1: of Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes

Andreea-Manuela Mirea (5816870)
Erik Toonen (5816864)
Inge Munckhof (6660734)
Isabelle Munsterman (6660737)
Eric Tjwa (6660740)
Martin Jaeger (3465044)
Marije Oosting (202291)
Kiki Schraa (527370)
Joost Rutten (6660743)
Marinette Graaf (6660746)
Niels Riksen (6660749)
Jacqueline Graaf (4259950)
Mihai Netea (3465053)
Cees Tack (5816873)
Triantafyllos Chavakis (5816888)
Leo Joosten (26109)

May 2019

Figure S1. PR3 concentrations measured in plasma samples versus serum samples. (PPTX 65 kb

Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes

Mirea, A.M.
Toonenu, Erik J.M.
Munckhof, I.C. van den
Munsterman, I.D.
Tjwa, E.T.
Jaeger, M.
Oosting, M.
Schraa, K.
Rutten, J.H.W.
Graaf, M. van der
Riksen, N.P.
Graaf, J. de
Netea, M.G.
Tack, C.J.
Chavakis, T.
Joosten, L.A.B.

January 2019

Contains fulltext : 203691.pdf (publisher's version ) (Open Access

Additional file 1: of Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study

Fang Liu (13271)
Hui Zhou (13228)
Lei Cao (134409)
Zhirong Guo (3344273)
Chen Dong (967)
Lugang Yu (223712)
Yiying Wang (3344264)
Chunxing Liu (3344267)
Jing Qiu (273902)
Yong Xue (307664)
Xingxiang Liu (4440544)
Yunfang Xu (3344270)

September 2018

Table S1. Stratified analysis of NAFLD and platelet count in different subgroup. (DOCX 27 kb

Additional file 1: Table S1. of The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease

Shujun Zhang (314599)
Tingting Du (9414)
Jianhua Zhang (6347)
Huiming Lu (39961)
Xuan Lin (1716175)
Junhui Xie (3682897)
Yan Yang (33204)
Xuefeng Yu (329731)

January 2017

Odds ratios for NAFLD in different quartiles of TyG index or ALT in ALT <40 and âĽ40 U/L groups. Ta...

Additional file 3: of Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways

Glenn Gerhard (3518345)
Ivana Malenica (559417)
Lorida Llaci (5514833)
Xin Chu (1423066)
Anthony Petrick (5140781)
Christopher Still (3315645)
Johanna DiStefano (5140787)

July 2018

Figure S1. Box plot of mean (± standard deviation) methylation β values for CGI associated with gene...

Additional file 2: of Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults

Jing Luo (146659)
Qian Chen (18883)
Tianran Shen (1568260)
Xu Wang (28596)
Wanjun Fang (5948006)
Xiaocai Wu (5948009)
Zenan Yuan (5948012)
Gengdong Chen (5948015)
Wenhua Ling (163611)
Yuming Chen (108442)

November 2018

Table S2. Association of serum SHBG levels with metabolic risk factors using multiple linear regress...

Additional file 6: of Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease

Stephanie Breher-Esch (6088193)
Nishika Sahini (668877)
Anna Trincone (6088202)
Christin Wallstab (6088205)
JĂźrgen Borlak (6088208)

December 2018

Table S3. Compilation of NAFLD responsive genes in in-vitro/in-vivo comparisons. (PDF 96 kb

Activation of proteinase 3 contributes to Non-alcoholic Fatty Liver Disease (NAFLD) and insulin resistance

Toonen, E.J.M.
Mirea, A.M.
Tack, C.J.J.
Stienstra, R.
Ballak, D.B.
Diepen, J.A. van
Hijmans, A.G.M.
Chavakis, T.
Dokter, W.H.
Pham, C.T.
Netea, M.G.
Dinarello, C.A.
Joosten, L.A.B.

January 2016

Contains fulltext : 169891.pdf (publisher's version ) (Open Access)Activation of i...

Additional file 1: of Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study

Xiao Ren (1671724)
Dian Shi (6322961)
Jiao Ding (6322970)
Zhi Cheng (729515)
Hai Li (254910)
Juan Li (146180)
Hong Pu (5449697)
Ai Yang (6322982)
Cai He (2298781)
Jian Zhang (1682)
Yu Ma (111665)
Ya Zhang (7980)
Tong Zheng (113302)
Ya Bai (835303)
Ning Cheng (483330)

February 2019

Table S1. Relative Risk of some factors in normal and NAFLD groups. Table S2. Variable scoring list ...

Additional file 1: of Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults

Tilman Kühn (437324)
Tobias Nonnenmacher (5514371)
Disorn Sookthai (3495086)
Ruth Schübel (3397790)
Daniel Quintana Pacheco (5514377)
Oyunbileg von Stackelberg (5514374)
Mirja Graf (5514368)
Theron Johnson (3495092)
Christopher Schlett (5514380)
Romy Kirsten (5514383)
Cornelia Ulrich (3404738)
Rudolf Kaaks (23598)
Hans-Ulrich Kauczor (448631)
Johanna Nattenmüller (3687550)

July 2018

Electronic Supplementary Material: Figure S1. Histogram of MRI-derived liver fat content (%) values....

Additional file 1: of Effect of a high-protein diet with Î˛-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial

Fatemeh Haidari (4530547)
Abdollah Hojhabrimanesh (5984030)
Bizhan Helli (5984033)
Seyed Seyedian (5984036)
Kambiz Ahmadi-Angali (5984039)

November 2018

SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...

Additional file 1: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

June 2018

Table S1. Prevalence of comorbidities in overweight (Nâ=â14) and obese (12) NAFLD patients. In o...

Additional file 9: Figure S7. of Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

Christopher Papandreou (4411252)
Mònica Bullò (4411249)
Francisco Tinahones (211981)
Miguel Martínez-González (3555266)
Dolores Corella (108667)
Georgios Fragkiadakis (4411246)
José López-Miranda (3167316)
Ramon Estruch (108727)
Montserrat Fitó (540590)
Jordi Salas-Salvadó (108681)

September 2017

Volcano plot [−log10 (p-value) vs. log2 (fold-change)] for the comparison between the baseline and f...

Additional file 3: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

June 2018

Figure S2. FGF19 serum concentrations at 4 h versus C4 values at 6 h after the oral fat tolerance te...

Additional file 5: of Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes

Abstract

Extracted data

Additional file 5: of Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes

Abstract

Extracted data

Related items

Related items